The Effectiveness of Mental Wellness Youth Hubs in Hong Kong
Launched by THE UNIVERSITY OF HONG KONG · Mar 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective Mental Wellness Youth Hubs in Hong Kong are in reducing mental stress and improving the overall well-being of young people. The study will involve 600 youths aged 12 to 24 who are using these hub services and 600 young people from the community who are not using any mental health services. The researchers want to see if those using the hubs feel better, have a better quality of life, and function better compared to those who are not. They will also explore if certain groups, like those based on gender or socio-economic status, benefit more from these services.
To be eligible for the study, participants must be between 12 and 24 years old and not currently taking psychiatric medications or have a formal diagnosis of a mental health disorder. Participants in the hub group will receive support from the youth hub, while those in the control group will not receive any specialized services. The trial is not yet recruiting participants, but if you or someone you know is interested, it will be a chance to contribute to understanding how community support can help young people manage stress and improve their mental wellness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For hub user group: 12- to 24-year-old hub users who receive community-based mental wellness youth hub services for young people.
- • For community control group: 12- to 24-year-old community youths who do not receive any youth services in the community.
- • For eClinic user group: 12- to 24-year-old eClinic service users.
- Exclusion Criteria:
- • Youths with known diagnosis of psychiatric disorders (including Depression, Generalized Anxiety Disorder, Panic Disorder, Phobia, Obsessive Compulsive Disorder, Bipolar Disorder, Eating Disorder, Personality Disorder, Post-Traumatic Stress Disorder and Psychotic Disorder)
- • Youths who receive psychiatric medication (including antidepressants, antipsychotics and antiepileptic drugs)
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Christy Lai Ming Hui, PhD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported